Literature DB >> 7718512

Defective IL-5-receptor-mediated signaling in B cells of X-linked immunodeficient mice.

M Koike1, Y Kikuchi, A Tominaga, S Takaki, K Akagi, J Miyazaki, K Yamamura, K Takatsu.   

Abstract

Murine (m) IL-5 induces proliferation and differentiation of both Ly-1+ B cells and activated conventional B cells. X-linked immunodeficient (XID) mice do not respond to thymus-independent type II antigens, and have an abnormal response to a variety of activation signals through Ig receptors, CD40 and cytokine receptors. Furthermore, XID mice show a B cell specific defect, reflected in decreased numbers of IL-5R alpha+ B cells and reduced responsiveness of IL-5R alpha+ B cells to mIL-5. We generated IL-5R alpha transgenic (5R alpha-Tg) mice in which B cells expressed recombinant IL-5R alpha. We crossed male 5R alpha-Tg mice with female XID mice and used their offspring to determine the IL-5 responsiveness of these B cells. All B cells of F1 male mice carrying the xid gene together with the transgene expressed the recombinant IL-5R alpha. However, those mice lacked Ly-1 B cells and their B cells acquired responsiveness to mIL-5. Interestingly, XID-5R alpha-Tg B cells, but not XID B cells, acquired mIL-5 proliferative and Ig-secretory responsiveness only in the presence of suboptimal doses of lipopolysaccharide. Stimulation of these B cells with mIL-5 plus phorbol myristate acetate induced proliferation, but not Ig secretion. These results indicate that the impaired mIL-5 responsiveness of B cells in XID mice is due to an abnormality of IL-5R-mediated signaling which may correlate with the xid gene mutation, alteration of a single amino acid of Bruton's tyrosine kinase.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7718512     DOI: 10.1093/intimm/7.1.21

Source DB:  PubMed          Journal:  Int Immunol        ISSN: 0953-8178            Impact factor:   4.823


  10 in total

1.  In situ detection of activated Bruton's tyrosine kinase in the Ig signaling complex by phosphopeptide-specific monoclonal antibodies.

Authors:  S Nisitani; R M Kato; D J Rawlings; O N Witte; M I Wahl
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-02       Impact factor: 11.205

2.  Phosphorylation of two regulatory tyrosine residues in the activation of Bruton's tyrosine kinase via alternative receptors.

Authors:  M I Wahl; A C Fluckiger; R M Kato; H Park; O N Witte; D J Rawlings
Journal:  Proc Natl Acad Sci U S A       Date:  1997-10-14       Impact factor: 11.205

3.  Btk regulates multiple stages in the development and survival of B-1 cells.

Authors:  Cristina M Contreras; Kristina E Halcomb; Lindsey Randle; Rochelle M Hinman; Toni Gutierrez; Stephen H Clarke; Anne B Satterthwaite
Journal:  Mol Immunol       Date:  2007-01-04       Impact factor: 4.407

4.  A critical role of Lyn and Fyn for B cell responses to CD38 ligation and interleukin 5.

Authors:  T Yasue; H Nishizumi; S Aizawa; T Yamamoto; K Miyake; C Mizoguchi; S Uehara; Y Kikuchi; K Takatsu
Journal:  Proc Natl Acad Sci U S A       Date:  1997-09-16       Impact factor: 11.205

5.  Functional dissection of the cytoplasmic subregions of the interleukin-5 receptor alpha chain in growth and immunoglobulin G1 switch recombination of B cells.

Authors:  B G Moon; T Yoshida; M Shiiba; K Nakao; M Katsuki; S Takaki; K Takatsu
Journal:  Immunology       Date:  2001-03       Impact factor: 7.397

6.  Regulation of nuclear localization and transcriptional activity of TFII-I by Bruton's tyrosine kinase.

Authors:  C D Novina; S Kumar; U Bajpai; V Cheriyath; K Zhang; S Pillai; H H Wortis; A L Roy
Journal:  Mol Cell Biol       Date:  1999-07       Impact factor: 4.272

7.  CD38 ligation induces tyrosine phosphorylation of Bruton tyrosine kinase and enhanced expression of interleukin 5-receptor alpha chain: synergistic effects with interleukin 5.

Authors:  Y Kikuchi; T Yasue; K Miyake; M Kimoto; K Takatsu
Journal:  Proc Natl Acad Sci U S A       Date:  1995-12-05       Impact factor: 11.205

8.  Independent and opposing roles for Btk and lyn in B and myeloid signaling pathways.

Authors:  A B Satterthwaite; C A Lowell; W N Khan; P Sideras; F W Alt; O N Witte
Journal:  J Exp Med       Date:  1998-09-07       Impact factor: 14.307

9.  Bruton's tyrosine kinase links the B cell receptor to nuclear factor kappaB activation.

Authors:  U D Bajpai; K Zhang; M Teutsch; R Sen; H H Wortis
Journal:  J Exp Med       Date:  2000-05-15       Impact factor: 14.307

Review 10.  Targeting Bruton's Tyrosine Kinase in Inflammatory and Autoimmune Pathologies.

Authors:  Stefan F H Neys; Rudi W Hendriks; Odilia B J Corneth
Journal:  Front Cell Dev Biol       Date:  2021-06-04
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.